RFG Advisory LLC boosted its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 23.8% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 37,721 shares of the real estate investment trust's stock after buying an additional 7,242 shares during the quarter. RFG Advisory LLC's holdings in Omega Healthcare Investors were worth $1,382,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Vanguard Group Inc. raised its position in shares of Omega Healthcare Investors by 3.9% during the 1st quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust's stock valued at $1,506,250,000 after acquiring an additional 1,492,904 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Omega Healthcare Investors by 2.9% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 4,100,891 shares of the real estate investment trust's stock valued at $156,162,000 after acquiring an additional 114,665 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Omega Healthcare Investors by 4.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,058,107 shares of the real estate investment trust's stock valued at $154,533,000 after acquiring an additional 165,554 shares during the last quarter. Bank of New York Mellon Corp raised its position in shares of Omega Healthcare Investors by 6.4% during the 1st quarter. Bank of New York Mellon Corp now owns 3,123,152 shares of the real estate investment trust's stock valued at $118,930,000 after acquiring an additional 188,481 shares during the last quarter. Finally, AQR Capital Management LLC raised its position in shares of Omega Healthcare Investors by 430.8% during the 1st quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust's stock valued at $108,989,000 after acquiring an additional 2,322,878 shares during the last quarter. Institutional investors own 65.25% of the company's stock.
Wall Street Analysts Forecast Growth
OHI has been the subject of several recent research reports. Raymond James Financial reiterated an "outperform" rating on shares of Omega Healthcare Investors in a research report on Tuesday, September 2nd. Scotiabank upped their target price on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a "sector perform" rating in a research report on Thursday, August 28th. Weiss Ratings reiterated a "buy (b)" rating on shares of Omega Healthcare Investors in a research report on Wednesday, October 8th. Cantor Fitzgerald started coverage on shares of Omega Healthcare Investors in a research report on Wednesday, October 1st. They issued an "overweight" rating and a $50.00 price objective for the company. Finally, Mizuho upped their price objective on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a "neutral" rating in a research report on Thursday, September 11th. Seven equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $44.44.
Read Our Latest Analysis on OHI
Omega Healthcare Investors Price Performance
OHI opened at $40.37 on Friday. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. Omega Healthcare Investors, Inc. has a 12 month low of $35.04 and a 12 month high of $44.42. The company has a fifty day simple moving average of $41.56 and a 200 day simple moving average of $38.86. The stock has a market cap of $11.91 billion, a P/E ratio of 24.92, a P/E/G ratio of 1.87 and a beta of 0.70.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. The business had revenue of $235.60 million during the quarter, compared to analysts' expectations of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The firm's quarterly revenue was up 11.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, research analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.
Omega Healthcare Investors Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were issued a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 6.6%. The ex-dividend date was Monday, August 4th. Omega Healthcare Investors's dividend payout ratio is 165.43%.
Insider Transactions at Omega Healthcare Investors
In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the transaction, the director owned 18,654 shares in the company, valued at approximately $749,144.64. This represents a 11.82% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.50% of the company's stock.
About Omega Healthcare Investors
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.